Asia-Pacific Drug of Abuse Testing Market Report 2018

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Drug of Abuse Testing Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance(Volume)
  • 2.1.1 Onsite Screening Test Market Performance (Volume)
  • 2.1.2 Laboratory Drug Testing Market Performance (Volume)
• 2.2 Overall Market Performance(Value)
  • 2.1.1 Onsite Screening Test Market Performance (Value)
  • 2.1.2 Laboratory Drug Testing Market Performance (Value)

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
  • 3.1.1 Urine Market Performance (Volume)
  • 3.1.2 Hair Market Performance (Volume)
  • 3.1.3 Saliva Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Roche Holding Limited
  • 4.1.1 Roche Holding Limited Profiles
  • 4.1.2 Roche Holding Limited Product Information
  • 4.1.3 Roche Holding Limited Drug of Abuse Testing Business Performance
  • 4.1.4 Roche Holding Limited Drug of Abuse Testing Business Development and Market Status
• 4.2 Quest Diagnostics
  • 4.2.1 Quest Diagnostics Profiles
  • 4.2.2 Quest Diagnostics Product Information
  • 4.2.3 Quest Diagnostics Drug of Abuse Testing Business Performance
  • 4.2.4 Quest Diagnostics Drug of Abuse Testing Business Development and Market Status
• 4.3 Laboratory Corporation of America Holdings
  • 4.3.1 Laboratory Corporation of America Holdings Profiles
  • 4.3.2 Laboratory Corporation of America Holdings Product Information
  • 4.3.3 Laboratory Corporation of America Holdings Drug of Abuse Testing Business Performance
  • 4.3.4 Laboratory Corporation of America Holdings Drug of Abuse Testing Business Development and Market Status
• 4.4 Alere Inc
  • 4.4.1 Alere Inc Profiles
  • 4.4.2 Alere Inc Product Information
  • 4.4.3 Alere Inc Drug of Abuse Testing Business Performance
  • 4.4.4 Alere Inc Drug of Abuse Testing Business Development and Market Status
• 4.5 Abbott Laboratories
  • 4.5.1 Abbott Laboratories Profiles
  • 4.5.2 Abbott Laboratories Product Information
  • 4.5.3 Abbott Laboratories Drug of Abuse Testing Business Performance
  • 4.5.4 Abbott Laboratories Drug of Abuse Testing Business Development and Market Status
• 4.6 Randox Laboratories
  • 4.6.1 Randox Laboratories Profiles
  • 4.6.2 Randox Laboratories Product Information
  • 4.6.3 Randox Laboratories Drug of Abuse Testing Business Performance
  • 4.6.4 Randox Laboratories Drug of Abuse Testing Business Development and Market Status
• 4.7 Psychemedics Corporation
  • 4.7.1 Psychemedics Corporation Profiles
  • 4.7.2 Psychemedics Corporation Product Information
  • 4.7.3 Psychemedics Corporation Drug of Abuse Testing Business Performance
  • 4.7.4 Psychemedics Corporation Drug of Abuse Testing Business Development and Market Status
• 4.8 Bio-Rad Laboratories
  • 4.8.1 Bio-Rad Laboratories Profiles
  • 4.8.2 Bio-Rad Laboratories Product Information
  • 4.8.3 Bio-Rad Laboratories Drug of Abuse Testing Business Performance
  • 4.8.4 Bio-Rad Laboratories Drug of Abuse Testing Business Development and Market Status
• 4.9 Sonic Healthcare
  • 4.9.1 Sonic Healthcare Profiles
  • 4.9.2 Sonic Healthcare Product Information
  • 4.9.3 Sonic Healthcare Drug of Abuse Testing Business Performance
  • 4.9.4 Sonic Healthcare Drug of Abuse Testing Business Development and Market Status
• 4.10 Thermo Fisher Scientific Inc
  • 4.10.1 Thermo Fisher Scientific Inc Profiles
  • 4.10.2 Thermo Fisher Scientific Inc Product Information
  • 4.10.3 Thermo Fisher Scientific Inc Drug of Abuse Testing Business Performance
  • 4.10.4 Thermo Fisher Scientific Inc Drug of Abuse Testing Business Development and Market Status

5 Market Performance for Manufacturers

• 5.1 Asia-Pacific Drug of Abuse Testing Sales (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Asia-Pacific Drug of Abuse Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Asia-Pacific Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Asia-Pacific Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Regions Market Performance for Manufacturers

• 6.1 China Market Performance for Manufacturers
  • 6.1.1 China Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.1.2 China Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.1.3 China Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.1.4 China Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.1.5 Market Concentration
• 6.2 Japan Market Performance for Manufacturers
  • 6.2.1 Japan Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.2.2 Japan Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.2.3 Japan Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.2.4 Japan Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.2.5 Market Concentration
• 6.3 South Korea Market Performance for Manufacturers
  • 6.3.1 South Korea Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.3.2 South Korea Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.3.3 South Korea Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.3.4 South Korea Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.3.5 Market Concentration
• 6.4 Taiwan Market Performance for Manufacturers
  • 6.4.1 Taiwan Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.4.2 Taiwan Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.4.3 Taiwan Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.4.4 Taiwan Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.4.5 Market Concentration
• 6.5 India Market Performance for Manufacturers
  • 6.5.1 India Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.5.2 India Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.5.3 India Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.5.4 India Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.5.5 Market Concentration
• 6.6 Southeast Asia Market Performance for Manufacturers
  • 6.6.1 Southeast Asia Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.6.2 Southeast Asia Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.6.3 Southeast Asia Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.6.4 Southeast Asia Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.6.5 Market Concentration
• 6.7 Australia Market Performance for Manufacturers
  • 6.7.1 Australia Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.7.2 Australia Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.7.3 Australia Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.7.4 Australia Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.7.5 Market Concentration
• 6.8 Market Performance for Manufacturers
  • 6.8.1 Drug of Abuse Testing Sales (K Units) and Share of Manufacturers 2013-2018
  • 6.8.2 Drug of Abuse Testing Revenue (M USD) and Share of Manufacturers 2013-2018
  • 6.8.3 Drug of Abuse Testing Price (USD/Unit) of Manufacturers 2013-2018
  • 6.8.4 Drug of Abuse Testing Gross Margin of Manufacturers 2013-2018
  • 6.8.5 Market Concentration

7 Asia-Pacific Drug of Abuse Testing Market Performance (Sales Point)

• 7.1 Asia-Pacific Drug of Abuse Testing Sales (K Units) and Market Share by Regions 2013-2018
• 7.2 Asia-Pacific Drug of Abuse Testing Revenue (M USD) and Market Share by Regions 2013-2018
• 7.3 Asia-Pacific Drug of Abuse Testing Price (USD/Unit) by Regions 2013-2018
• 7.4 Asia-Pacific Drug of Abuse Testing Gross Margin by Regions 2013-2018

8 Development Trend for Regions (Sales Point)

• 8.1 Asia-Pacific Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.2 China Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.3 Japan Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.4 South Korea Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.5 Taiwan Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.6 India Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.7 Southeast Asia Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018
• 8.8 Australia Drug of Abuse Testing Sales and Growth, Sales Value and Growth Rate2013-2018

9 Upstream Source, Technology and Cost

• 9.1 Upstream Source
• 9.2 Technology
• 9.3 Cost

10 Channel Analysis

• 10.1 Market Channel
• 10.2 Distributors

11 Consumer Analysis

• 11.1 Urine Industry
• 11.2 Hair Industry
• 11.3 Saliva Industry

12 Market Forecast 2019-2024

• 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 12.1.1 Asia-Pacific Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 12.1.2 Asia-Pacific Drug of Abuse Testing Sales (K Units) and Growth Rate 2019-2024
  • 12.1.3 China Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.4 Japan Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.5 South Korea Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.6 Taiwan Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.7 India Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.8 Southeast Asia Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.9 Australia Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.1.10 Drug of Abuse Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
  • 12.3.1 Overall Market Performance
  • 12.3.2 Onsite Screening Test Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 12.3.3 Laboratory Drug Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 12.4 Sales by Application 2019-2024
  • 12.4.1 Overall Market Performance
  • 12.4.2 Urine Sales and and Growth Rate 2019-2024
  • 12.4.3 Hair Sales and and Growth Rate 2019-2024
  • 12.4.4 Saliva Sales and and Growth Rate 2019-2024
• 12.5 Price (USD/Unit) and Gross Profit
  • 12.5.1 Asia-Pacific Drug of Abuse Testing Price (USD/Unit) Trend 2019-2024
  • 12.5.2 Asia-Pacific Drug of Abuse Testing Gross Profit Trend 2019-2024

13 Conclusion